drugset / Trial / NCT03192943
A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability for the combination therapy of BMS-986205 and Nivolumab in patients with advanced tumors
Timeline
- Start
- 2017-06-23
- Primary completion
- 2018-12-11
- Completion
- 2018-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LINRODOSTAT | Small molecule | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |